Cargando…

Assessing Cerebrovascular Resistance in Patients With Sickle Cell Disease

In patients with sickle cell disease (SCD) the delivery of oxygen to the brain is compromised by anemia, abnormal rheology, and steno-occlusive vascular disease. Meeting demands for oxygen delivery requires compensatory features of brain perfusion. The cerebral vasculature’s regulatory function and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayin, Ece Su, Sobczyk, Olivia, Poublanc, Julien, Mikulis, David J., Fisher, Joseph A., Kuo, Kevin H. M., Duffin, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002264/
https://www.ncbi.nlm.nih.gov/pubmed/35422710
http://dx.doi.org/10.3389/fphys.2022.847969
_version_ 1784685853682958336
author Sayin, Ece Su
Sobczyk, Olivia
Poublanc, Julien
Mikulis, David J.
Fisher, Joseph A.
Kuo, Kevin H. M.
Duffin, James
author_facet Sayin, Ece Su
Sobczyk, Olivia
Poublanc, Julien
Mikulis, David J.
Fisher, Joseph A.
Kuo, Kevin H. M.
Duffin, James
author_sort Sayin, Ece Su
collection PubMed
description In patients with sickle cell disease (SCD) the delivery of oxygen to the brain is compromised by anemia, abnormal rheology, and steno-occlusive vascular disease. Meeting demands for oxygen delivery requires compensatory features of brain perfusion. The cerebral vasculature’s regulatory function and reserves can be assessed by observing the flow response to a vasoactive stimulus. In a traditional approach we measured voxel-wise change in Blood Oxygen-Level Dependent (BOLD) MRI signal as a surrogate of cerebral blood flow (CBF) in response to a linear progressive ramping of end-tidal partial pressure of carbon dioxide (PETCO(2)). Cerebrovascular reactivity (CVR) was defined as ΔBOLD/ΔPETCO(2). We used a computer model to fit a virtual sigmoid resistance curve to the progressive CBF response to the stimulus, enabling the calculation of resistance parameters: amplitude, midpoint, range response, resistance sensitivity and vasodilatory reserve. The quality of the resistance sigmoid fit was expressed as the r (2) of the fit. We tested 35 patients with SCD, as well as 24 healthy subjects to provide an indication of the normal ranges of the resistance parameters. We found that gray matter CVR and resistance amplitude, range, reserve, and sensitivity are reduced in patients with SCD compared to healthy controls, while resistance midpoint was increased. This study is the first to document resistance measures in adult patients with SCD. It is also the first to score these vascular resistance measures in comparison to the normal range. We anticipate these data will complement the current understanding of the cerebral vascular pathophysiology of SCD, identify paths for therapeutic interventions, and provide biomarkers for monitoring the progress of the disease.
format Online
Article
Text
id pubmed-9002264
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90022642022-04-13 Assessing Cerebrovascular Resistance in Patients With Sickle Cell Disease Sayin, Ece Su Sobczyk, Olivia Poublanc, Julien Mikulis, David J. Fisher, Joseph A. Kuo, Kevin H. M. Duffin, James Front Physiol Physiology In patients with sickle cell disease (SCD) the delivery of oxygen to the brain is compromised by anemia, abnormal rheology, and steno-occlusive vascular disease. Meeting demands for oxygen delivery requires compensatory features of brain perfusion. The cerebral vasculature’s regulatory function and reserves can be assessed by observing the flow response to a vasoactive stimulus. In a traditional approach we measured voxel-wise change in Blood Oxygen-Level Dependent (BOLD) MRI signal as a surrogate of cerebral blood flow (CBF) in response to a linear progressive ramping of end-tidal partial pressure of carbon dioxide (PETCO(2)). Cerebrovascular reactivity (CVR) was defined as ΔBOLD/ΔPETCO(2). We used a computer model to fit a virtual sigmoid resistance curve to the progressive CBF response to the stimulus, enabling the calculation of resistance parameters: amplitude, midpoint, range response, resistance sensitivity and vasodilatory reserve. The quality of the resistance sigmoid fit was expressed as the r (2) of the fit. We tested 35 patients with SCD, as well as 24 healthy subjects to provide an indication of the normal ranges of the resistance parameters. We found that gray matter CVR and resistance amplitude, range, reserve, and sensitivity are reduced in patients with SCD compared to healthy controls, while resistance midpoint was increased. This study is the first to document resistance measures in adult patients with SCD. It is also the first to score these vascular resistance measures in comparison to the normal range. We anticipate these data will complement the current understanding of the cerebral vascular pathophysiology of SCD, identify paths for therapeutic interventions, and provide biomarkers for monitoring the progress of the disease. Frontiers Media S.A. 2022-03-29 /pmc/articles/PMC9002264/ /pubmed/35422710 http://dx.doi.org/10.3389/fphys.2022.847969 Text en Copyright © 2022 Sayin, Sobczyk, Poublanc, Mikulis, Fisher, Kuo and Duffin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Sayin, Ece Su
Sobczyk, Olivia
Poublanc, Julien
Mikulis, David J.
Fisher, Joseph A.
Kuo, Kevin H. M.
Duffin, James
Assessing Cerebrovascular Resistance in Patients With Sickle Cell Disease
title Assessing Cerebrovascular Resistance in Patients With Sickle Cell Disease
title_full Assessing Cerebrovascular Resistance in Patients With Sickle Cell Disease
title_fullStr Assessing Cerebrovascular Resistance in Patients With Sickle Cell Disease
title_full_unstemmed Assessing Cerebrovascular Resistance in Patients With Sickle Cell Disease
title_short Assessing Cerebrovascular Resistance in Patients With Sickle Cell Disease
title_sort assessing cerebrovascular resistance in patients with sickle cell disease
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002264/
https://www.ncbi.nlm.nih.gov/pubmed/35422710
http://dx.doi.org/10.3389/fphys.2022.847969
work_keys_str_mv AT sayinecesu assessingcerebrovascularresistanceinpatientswithsicklecelldisease
AT sobczykolivia assessingcerebrovascularresistanceinpatientswithsicklecelldisease
AT poublancjulien assessingcerebrovascularresistanceinpatientswithsicklecelldisease
AT mikulisdavidj assessingcerebrovascularresistanceinpatientswithsicklecelldisease
AT fisherjosepha assessingcerebrovascularresistanceinpatientswithsicklecelldisease
AT kuokevinhm assessingcerebrovascularresistanceinpatientswithsicklecelldisease
AT duffinjames assessingcerebrovascularresistanceinpatientswithsicklecelldisease